Recruiting Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma NCT06620302 Conditions Childhood Fibrolamellar Carcinoma, Fibrolamellar hepatocellular carcinoma, Recurrent Childhood Fibrolamellar Carcinoma, +7 more Locations Children's Hospital of Alabama — Birmingham, Alabama, United States Children's Hospital Los Angeles — Los Angeles, California, United States Children's Hospital of Orange County — Orange, California, United States UCSF Medical Center-Mission Bay — San Francisco, California, United States View all 21 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling NCT05857969 Conditions Bone Marrow Diseases, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +38 more Locations Nicklaus Children's Hospital — Miami, Florida, United States View Trial Details
